Cargando…
Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery
PURPOSE: To analyze the outcomes of chemoradiotherapy for extrahepatic bile duct (EHBD) cancer patients who underwent R2 resection or bypass surgery and to identify prognostic factors affecting clinical outcomes, especially in terms of molecular biomarkers. MATERIALS AND METHODS: Medical records of...
Autores principales: | Koh, Hyeon Kang, Park, Hae Jin, Kim, Kyubo, Chie, Eui Kyu, Min, Hye Sook, Ha, Sung W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546288/ https://www.ncbi.nlm.nih.gov/pubmed/23346539 http://dx.doi.org/10.3857/roj.2012.30.4.197 |
Ejemplares similares
-
Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives
por: Koo, Taeryool, et al.
Publicado: (2019) -
Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution
por: Kim, Byoung Hyuck, et al.
Publicado: (2017) -
Radiation therapy for recurrent extrahepatic bile duct cancer
por: Koh, Minji, et al.
Publicado: (2021) -
Primary Extrahepatic Bile Duct Carcinoids
por: Belli, Giulio, et al.
Publicado: (1996) -
Adenosquamous Carcinoma of the Extrahepatic Bile Duct
por: Gupta, Deepika, et al.
Publicado: (2022)